Comparative Pharmacology
Head-to-head clinical analysis: MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER versus SODIUM CHLORIDE 0 9 AND POTASSIUM CHLORIDE 0 075.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER versus SODIUM CHLORIDE 0 9 AND POTASSIUM CHLORIDE 0 075.
MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER vs SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.075%
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Magnesium sulfate provides magnesium ions, which are essential for various physiological processes. It acts as a cofactor for enzymatic reactions, stabilizes excitable membranes, and antagonizes calcium entry at the neuromuscular junction, leading to reduced acetylcholine release and muscle relaxation. In the CNS, it may act as a noncompetitive antagonist of NMDA receptors, exerting anticonvulsant effects.
Sodium chloride and potassium chloride are electrolytes that maintain osmotic balance, fluid distribution, and proper cellular function. Sodium is the primary extracellular cation involved in fluid balance, nerve impulse transmission, and muscle contraction. Potassium is the major intracellular cation essential for cardiac, skeletal, and smooth muscle activity, and acid-base balance.
1 to 4 g intravenously as a 5% to 20% solution, rate not exceeding 150 mg/min; dosing frequency depends on indication (e.g., preeclampsia/eclampsia: 4-5 g IV loading then 1-2 g/hr infusion; hypomagnesemia: 1-2 g IV over 1-2 hours, may repeat based on serum magnesium levels).
Intravenous infusion; typical adult dose is 1-2 mL/kg/hr adjusted based on serum electrolyte levels and fluid status. For maintenance, 30 mL/kg/day of 0.9% sodium chloride with 0.075% potassium chloride (KCl 10 mEq/L) at a rate of 100-125 mL/hr. Not to exceed 20 mEq KCl per hour.
None Documented
None Documented
Terminal half-life approximately 4-5 hours in normal renal function; prolonged in renal impairment (up to 40 hours).
Sodium and potassium have no true terminal half-life as they are homeostatically regulated. In steady-state, sodium turnover half-life is approximately 2-3 weeks, while potassium has a faster turnover of about 40 hours in skeletal muscle. Clinically, redistribution after IV infusion occurs within hours, with renal excretion adapting rapidly.
Primarily renal (90-100% as unchanged magnesium). Less than 1% biliary/fecal.
Sodium and potassium ions are primarily excreted renally. Sodium elimination follows glomerular filtration with 99% tubular reabsorption, while potassium is filtered, then 90% is reabsorbed in proximal tubule and loop of Henle, with distal secretion regulated by aldosterone. Fecal excretion is minimal (<5%) under normal conditions.
Category C
Category A/B
Electrolyte
Electrolyte